Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial

Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial

<i>Purpose</i>: This study was completed to assess the immunogenicity and safety of the FAKHRAVAC and BBIBP-CorV vaccines as a booster dose in the population with a history of receiving two doses of BBIBP-CorV vaccine. <i>Methods</i>: In this double-blind, parallel clinical t...

Full description

Bibliographic Details
Main Authors: Mohammadreza Ahi, Ramin Hamidi Farahani, Pouria Basiri, Ahmad Karimi Rahjerdi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Fatemeh Gholami, Milad Moradi, Farzad Ghafoori Naeeni, Kosar Naderi Saffar, Soheil Ghasemi, Babak Barati, Sohrab Moradi, Arina Monazah, Fatemeh Pouranvari, Mohsen Forooghizadeh
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Vaccines
Subjects:
immunogenicity
safety
FAKHRAVAC<sup>®</sup>
BBIBP-CorV
clinical trial
neutralizing antibody (Nab) and booster-dose injection
Online Access:https://www.mdpi.com/2076-393X/10/11/1800

Similar Items

Similar Items